Thomas A. Raffin, Director at NEWLINK GENETICS CORP (NLNK), sold 20,694 shares at $53.18 ($1.1M) on 2015-04-07, disclosed to the SEC on 2015-04-09.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.18 | 800 | $43K | 3.8% |
| 2 | $54.32 | 10,024 | $545K | 48.2% |
| 3 | $55.03 | 9,870 | $543K | 48.1% |
| Total | $54.61 avg | 20,694 | $1.1M | 100% |
| Filing → |
| LDRH | SELL | 2015-02-23 | $8.5M | — | Filing → |
| LDRH | SELL | 2014-10-01 | $884K | — | Filing → |
| LDRH | SELL | 2014-09-26 | $6.2M | — | Filing → |